Pharmacological evidence that spinal α2C- and, to a lesser extent, α2A-adrenoceptors inhibit capsaicin-induced vasodilatation in the canine external carotid circulation-Reference-Cited by-同舟云学术

Pharmacological evidence that spinal α2C- and, to a lesser extent, α2A-adrenoceptors inhibit capsaicin-induced vasodilatation in the canine external carotid circulation

Published:2012-05 Issue:1-3 Volume:683 Page:204-210
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Villalón Carlos M.,Galicia-Carreón Jorge,González-Hernández Abimael,Marichal-Cancino Bruno A.,Manrique-Maldonado Guadalupe,Centurión David

Funder

CONACyT

Publisher

Elsevier BV

Subject

Pharmacology

Reference50 articles.

1. Calcitonin gene-related peptide and its role in migraine pathophysiology;Arulmani;Eur. J. Pharmacol.,2004

2. Subtypes of α1- and α2-adrenergic receptors;Bylund;FASEB J.,1992

3. International Union of Pharmacology nomenclature of adrenoceptors;Bylund;Pharmacol. Rev.,1994

4. The capsaicin receptor: a heat-activated ion channel in the pain pathway;Caterina;Nature,1997

5. Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model;Chan;Br. J. Pharmacol.,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The differential in vivo contribution of spinal α2A- and α2C-adrenoceptors in tonic and acute evoked nociception in the rat;Frontiers in Pharmacology;2022-11-23

2. A critical review of the neurovascular nature of migraine and the main mechanisms of action of prophylactic antimigraine medications;Expert Review of Neurotherapeutics;2021-09-02

3. An outlook on the trigeminovascular mechanisms of action and side effects concerns of some potential neuropeptidergic antimigraine therapies;Expert Opinion on Drug Metabolism & Toxicology;2021-01-20

4. Migraine and Ischemic Stroke: Deciphering the Bidirectional Pathway;ACS Chemical Neuroscience;2020-04-29

5. Side effects associated with current and prospective antimigraine pharmacotherapies;Expert Opinion on Drug Metabolism & Toxicology;2017-12-15